tbuckley/cabot-search huggingface dataset:
Safety and Efficacy of Orca-Q with Haploidentical Donors for the Treatment of Advanced Hematologic Malignancies without the Use of Post-Transplant Cyclophosphamide
Authors: Samer A. Srour, Amandeep Salhotra, Robert Lowsky, Rasmus T. Hoeg, Edmund K. Waller, Anna Pavlova, J. Scott McClellan, Nathaniel B. Fernhoff, Everett H. Meyer, Mehrdad Abedi
Journal: Blood (2023)
Personalized Residual Disease Detection in Acute Myeloid Leukemia with a Multiplexed Genomic Fingerprint Predicts Patient Outcomes
Authors: Andrea B Moffitt, Joan Alexander, Asya Stepansky, Erin Boyle, Danielle Stauder, Carlos Alberto Lopez, Vernon Wu, Nausheen Hakim, Zihua Wang, Jonathan E Kolitz, Nicholas Chiorazzi, David W Chitty, Steven L. Allen, Dan Levy, Michael Wigler
Journal: Blood (2023)
Pooled Analysis of Safety from Birtamimab Phase 1-3 Studies in Patients with Light Chain (AL) Amyloidosis
Authors: Vaishali Sanchorawala, Ashutosh D Wechalekar, Efstathios Kastritis, Giovanni Palladini, Stefan Schönland, Raymond Comenzo, Anita D'Souza, Jack Khouri, Victor Jimenez-Zepeda, Katherine Ingrid Sprinz, Heather Hao, Wenying Huang, Laura Governale Aubrey, Morie A. Gertz
Journal: Blood (2023)
The Post-CAR Prognostic Index (PC-PI): A New Prognostic Score to Predict Overall Survival in Large B-Cell Lymphoma Patients Progressing after Chimeric Antigen Receptor T-Cell Therapy
Authors: Gloria Iacoboni, Victor Navarro Garces, Josu Iraola, Pierre Sesques, Kai Rejeski, Fabio Serpenti, Mariana Bastos-Oreiro, ANA Africa Martin Lopez, Javier Delgado, Ariadna Perez, Manuel Guerreiro, Ana Carolina Caballero Gonzalez, Nuria Martinez-Cibrian, Hugo Daniel Luzardo Henriquez, Jose Maria Sanchez Pina, Juan-Manuel Sancho, Herve Ghesquieres, Alberto Mussetti, Pere Barba, Lucia Lopez Corral, Rafael Hernani, Juan Luis Reguera, Anna Maria Sureda Balari, Francesc Bosch, Alejandro Martin Garcia-Sancho, Mi Kwon, Andrea Kuhnl, Marion Subklewe, Emmanuel Bachy, Guillermo Villacampa, Pau Abrisqueta Costa
Journal: Blood (2023)
Patient-Reported Outcomes (PROs) from the Phase 2 TRANSCEND FL Study of Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory Follicular Lymphoma (FL)
Authors: Guillaume Cartron, Alejandro Martin Garcia-Sancho, Juan Luis Reguera, Saurabh Dahiya, Shien Guo, Ling Shi, Laurie Eliason, Jinender Kumar, Thalia Farazi, Omotayo Fasan, Koji Izutsu
Journal: Blood (2023)
Efficacy and Tolerance of Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia : A Graall Study from the Descar-T Registry
Authors: Florence Rabian, David Beauvais, Tony Marchand, Sabine Furst, Anne Huynh, Eolia Brissot, Sebastien Maury, Ludovic Gabellier, Patrice Chevallier, Michael Loschi, Stéphanie Nguyen Quoc, Marie Balsat, Ingrid Lafon, Amandine Fayard, Vincent Camus, Célestine Simand, Niels Moya, Cristina Castilla-Llorente, Magalie Joris, Ana Berceanu, Anne Thiebaut, Véronique Lhéritier, Eve Gehlkopf, Gabrielle Roth-Guepin, Thibaut Leguay, Nicolas Boissel
Journal: Blood (2023)
Inactivation of DNA Polymerase Theta (PolΘ) Is Synthetic Lethal in DNMT3A Mutated Myeloid Malignancies - Potential Clinical Applications
Authors: Bac Viet Le, Umeshkumar Vekariya, Monika Toma, Margaret Nieborowska-Skorska, Marie-Christine Caron, George Vassiliou, Malgorzata Gozdecka, Zayd Haydar, Gurushankar Chandramouly, Emir Hadzijusufovic, Wolfgang R. Sperr, Richard Pomerantz, Peter Valent, Jean-Yves Masson, Gaorav Gupta, Grant A Challen, Tomasz Skorski
Journal: Blood (2023)
Tazemetostat in Combination with R-CHOP in Patients with High-Risk, Frontline Follicular Lymphoma (Epi-RCHOP): A Phase II Study from the Lysa
Authors: Loic Ysebaert, Francois Lemonnier, Gabriel Brisou, Olivier Casasnovas, Gian Matteo Pica, Emmanuel Bachy, Ludovic Fouillet, Julie Abraham, Stephanie Guidez, Marc André, Guillaume Cartron, Romain Guieze, Sylvain Carras, Benoit Tessoulin, Roch Houot, Bohrane Slama, Christophe Bonnet, Luc-Matthieu Fornecker, Marie-Helene Delfau, Clementine Sarkozy, Camille Laurent, Vincent Ribrag, Franck Morschhauser
Journal: Blood (2023)
Lymphoma-Derived IL-10 Is a Key Immunomodulatory Factor at the Tumor Microenvironment of Activated B-Cell Diffuse Large B-Cell Lymphoma and Influences In Vivo Responses to Immunotherapy
Authors: Marcos Garcia-Lacarte, Sara C Grijalba, Francisco J Novo, Adrián Arnaiz-Leché, Javier Melchor, Marién Pascual, Enrique Goñi, Sandra Morales-Sánchez, María A Burrell, Oscar Blanco, Iñigo Clemente-Larramendi, Jose A Martinez-Climent, Noelia Casares, Juan J Lasarte, Pablo Sarobe, Miguel Canales, Sergio Roa
Journal: Blood (2023)
Patterns of Cytokine Release Syndrome with Teclistamab in Relapsed/Refractory Multiple Myeloma with or without Prior T-Cell Redirection Therapy
Authors: Issam S. Hamadeh, Tala Shekarkhand, Colin Rueda, Ross Firestone, Alice Wang, Neha Korde, Malin Hultcrantz, Alexander Lesokhin, Sham Mailankody, Hani Hassoun, Urvi A Shah, Kylee H Maclachlan, Dhwani Patel, Gunjan L. Shah, Michael Scordo, Oscar Boutros Lahoud, David Chung, Heather Landau, Sergio A. Giralt, Saad Z Usmani, Carlyn Rose Tan
Journal: Blood (2023)
Should the European Leukemia Net 2022 Adverse Risk Classification of <i>NPM1</i> mutated Acute Myeloid Leukemia be Revisited? Among Adverse Risk Cytogenetics, Solely Complex Karyotype Is Associated with Worse Post-Transplant Survival: A Study from the EBMT Acute Leukemia Working Party
Authors: Nour Moukalled, Myriam Labopin, Jurjen Versluis, Gerard Socié, Didier Blaise, Urpu Salmenniemi, Alessandro Rambaldi, Tobias Gedde-Dahl, Eleni Tholouli, Nicolaus Kröger, Jean-Henri Bourhis, Peter A. Von Dem Borne, Etienne Daguindau, Édouard Forcade, Arnon Nagler, Jordi Esteve, Fabio Ciceri, Ali Bazarbachi, Mohamad Mohty
Journal: Blood (2023)
Treatment of Congenital Hypotransferrinemia Patients with Human Apotransferrin Resolves Anemia and Reduces Iron Accumulation
Authors: Ilona Kleine Budde, Cristina Díaz De Heredia, Raffaella Mariani, Alberto Piperno, Katja Moser, Mayka Sanchez, Thomas Bodewes, Maya Isaila
Journal: Blood (2023)
17R-Resolvin D1 Improves Inflammatory Cardiomyopathy in a Mouse Model of Sickle Cell Disease
Authors: Enrica Federti, Domenico Mattoscio, Antonio Recchiuti, Alessandro Mattè, Maria Monti, Flora Cozzolino, Martina Ceci, Manuela Iezzi, Angela Siciliano, Veronica Riccardi, Alice Passarini, Carlo Brugnara, Lucia De Franceschi
Journal: Blood (2023)
Immune Profiling and Responses of Smoldering Multiple Myeloma Patients Treated in a Phase Ib Study of Pvx-410 Vaccine Targeting XBP1/CD138/CS1 Antigens, and Citarinostat, a Histone Deacetylase Inhibitor (HDACi) with and without Lenalidomide
Authors: Diana Cirstea, Rajib Shome, Joseph James Connolly, Emilie Duvallet, Amanda N. R. Joyce, Victor Moyo, Kathleen Lively, Gina Basinsky, Andrew J. Yee, Cristiana Costa Chase, Ehsan Malek, Ruben Niesvizky, Paul G. Richardson, Noopur S. Raje
Journal: Blood (2023)
Safety and Efficacy of Axatilimab at 3 Different Doses in Patients with Chronic Graft-Versus-Host Disease (AGAVE-201)
Authors: Daniel Wolff, Corey Cutler, Stephanie J. Lee, Iskra Pusic, Henrique Bittencourt, Jennifer White, Mehdi Hamadani, Sally Arai, Amandeep Salhotra, Jose A. Pérez-Simón, Amin Alousi, Hannah Choe, Mi Kwon, Arancha Bermúdez, Inho Kim, Gerard Socié, Vedran Radojcic, Timothy O'Toole, Chuan Tian, Peter Ordentlich, Zachariah DeFilipp, Carrie L. Kitko
Journal: Blood (2023)
Patient, Caregiver, and Physician Perspectives on Communication in Diagnosing and Treating Higher-Risk Myelodysplastic Syndromes: A Qualitative Study
Authors: Melissa Culhane Maravic, Natalie Land, Nadya Prood, Kelly Birch, Claire Cagle, Suepattra G. May, Eduardo J. Sabate, Ngozi Afulezi, Teraneh Z. Jhaveri, Mindy Chen, Audrey Hassan, Islam Sadek, Cosmina Hogea
Journal: Blood (2023)
Inflammatory Memory Restrains Intestinal Stem Cell (ISC) Regeneration after Allogeneic Stem Cell Transplantation (SCT)
Authors: Dongchang Zhao, Visweswaran Ravikumar, Emma Lauder, Lu Li, Yaping Sun, Katherine Oravecz-Wilson, Michael Brooks, Evan Keller, Fengju Chen, Laure Maneix, Ana Santibanez, Chad Creighton, Arvind Rao, Pavan Reddy
Journal: Blood (2023)
Favezelimab in Combination with Pembrolizumab in Patients with Anti-PD-1-Naive Relapsed or Refractory Classical Hodgkin Lymphoma: Updated Analysis of an Open-Label Phase 1/2 Study
Authors: Nathalie A. Johnson, David Lavie, Peter Borchmann, Gareth P. Gregory, Alex F. Herrera, Leonard Minuk, Vladan Vucinic, Philippe Armand, Abraham Avigdor, Robin Gasiorowski, Yair Herishanu, Colm Keane, John Kuruvilla, Rachel Marceau West, Pallavi Pillai, Patricia Marinello, John Timmerman
Journal: Blood (2023)
Senescence and Mitochondrial Transfer Ability of Bone Marrow Mesenchymal Stromal Cells Influence Patterns of Alloreactivity after Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Romain Perouf, Meriem Hadid, Alexandra Guelton, Naceur Charif, Cecile Pochon, Maud D'Aveni, Simona Pagliuca, Marie-Thérèse Rubio, Natalia De Isla
Journal: Blood (2023)
A Phase II Multicenter Trial of Ruxolitinib to Treat Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation
Authors: Zachariah Defilipp, Haesook T. Kim, Guang-Shing Cheng, Saurabh Chhabra, Mehdi Hamadani, Karamjeet S. Sandhu, Betty K. Hamilton, Lia Perez, Catherine J. Lee, Timothy L Brennan, Cassandra Garrelts, Bergin M Brown, Kathleen Gallagher, Areej El-Jawahri, Yi-Bin Chen
Journal: Blood (2023)
Screening for Multiple Organ Damage in Indian Sickle Cell Disease Cohort- a Step Towards Comprehensive Care
Authors: Nikhil Sharad Shinde, Anita HARISH Nadkarni, Manisha R Madkaikar, Kalpna Gupta, Amit Kamble, Sourabh B Rajurkar, Snehal ANIL Pophali, Vinod DHANRAJ Umare
Journal: Blood (2023)
A First-in-Human Phase 1 Study of the Menin-KMT2A (MLL1) Inhibitor JNJ-75276617 in Adult Patients with Relapsed/Refractory Acute Leukemia Harboring <i>KMT2A</i> or <i>NPM1</i> Alterations
Authors: Elias Jabbour, Emma Searle, Maher Abdul-Hay, Sameem Abedin, Ibrahim Aldoss, Ana Alfonso Piérola, Juan Manuel Alonso-Dominguez, Patrice Chevallier, Carrye Cost, Nikki Daskalakis, Richard Dillon, Neil Dunavin, Jordi Esteve, Amir T. Fathi, Pasquale L. Fedele, Lucille Ferrante, Sylvain Garciaz, Christina Guttke, Emmanuel Gyan, Brett Hiebert, Min Chul Kwon, Jonathan Miller, Teng Fong Ng, Kathryn Packman, Ulrike Philippar, Arnaud Pigneux, Christian Recher, Olga Salamero, Madhu Sanga, Richard M Stone, Peter Tan, Jan Willem Thuring, Trevor Tucker, Paresh Vyas
Journal: Blood (2023)
Global Burden and Trends of Multiple Myeloma in High-Income North America Countries between 1990-2019, with Projections of Deaths to 2040: A Benchmarking Analysis for the Global Burden of Disease Study 2019
Authors: Dhruvkumar Gadhiya, Vishrant Amin, Yashkumar Kamani, Gaganapalle Mahesh, Kopal Kotak, Rani Ratheesh, Hardik Dineshbhai Desai
Journal: Blood (2023)
A c- <i>MPL</i> Splice Variant up-Regulated in Myeloproliferative Neoplasms Modulates Thrombopoietin Signaling and Induces Cycling of Hematopoietic Stem Cells and Inflammatory Progenitors
Authors: Linda Resar, Zanshe Thompson, Li Z Luo, Donna Marie Williams, Liping Li, Leslie Cope, Iliana Herrera, Ophelia Rogers, Alison R. Moliterno, Jerry L. Spivak
Journal: Blood (2023)
Predicting Toxicities in Older Adults with Non-Hodgkin Lymphoma (NHL) Receiving Systemic Chemotherapy: A Prospective Geriatric Assessment (GA) Study
Authors: Pallawi Torka, Esther Drill, Nivetha Ganesan, Mayan Oliveros, Alexander P. Boardman, Philip Caron, Kevin A. David, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paola Ghione, Steven M. Horwitz, Andrew M. Intlekofer, William Johnson, Anita Kumar, Jennifer Kimberly Lue, Alison Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, Robert Stuver, Santosha A Vardhana, Andrew D. Zelenetz, Gilles Salles, Paul A. Hamlin
Journal: Blood (2023)
Impact of Type of Hypomethylating Agent (HMA) Used on Outcomes of Patients (Pts) with Higher-Risk Myelodysplastic Syndromes/Neoplasms (HR-MDS) - a Large, Multicenter, Retrospective Analysis
Authors: Jan Philipp Bewersdorf, Tariq Kewan, Ondrej Blaha, Maximilian Stahl, Najla H Al Ali, Amy E. DeZern, Mikkael A. Sekeres, Geoffrey L Uy, Hetty E. Carraway, Pinkal Desai, Elizabeth A. Griffiths, Eytan M. Stein, Andrew M. Brunner, Christine M. McMahon, Joshua F. Zeidner, Michael R. Savona, Jessica M. Stempel, Namrata Sonia Chandhok, Rahul Ramaswamy, Gail J. Roboz, Benjamin Rolles, Eunice S. Wang, Amyah C. Harris, Maria L Amaya, Hayley Hawkins, Justin Grenet, Carmelo Gurnari, Rory M. Shallis, Zhuoer Xie, Jaroslaw P. Maciejewski, David A Sallman, Matteo Giovanni Della Porta, Rami S. Komrokji, Amer M. Zeidan
Journal: Blood (2023)
A Phase I Trial of Activated Donor-Derived Marrow Infiltrating Lymphocytes to Treat Relapsed Hematologic Malignancies after Allogeneic Transplantation with Post-Transplantation Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis
Authors: Joseph Rimando, Francesco Mazziotta, Alison Gareau, Maria Bettinotti, Jonathan Allen Webster, Syed Abbas Ali, Philip Imus, Mario Victor Lemas, Amy E. DeZern, Mark J. Levis, Marianna Zahurak, Ravi Varadhan, Richard F. Ambinder, Carol Huff, Ivana Gojo, Richard J. Jones, Ivan M. Borrello, Leo Luznik
Journal: Blood (2023)
Smaart Criz: Sickle Cell Mechanisms of Activation, Adhesion, Rheology, and Thrombosis (SMAART) in Response to P-Selectin Inhibition
Authors: Gianna G. Guzzardo, Meera Chitlur, Patrick C. Hines, Aliya U. Zaidi, Rasa Borhan, Kelsey Cinciarelli, Alexander K Glaros
Journal: Blood (2023)
Geographic and Racial Disparities in Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials Access for Diffuse Large B-Cell Lymphoma
Authors: Moazzam Shahzad, Muhammad Fareed Khalid, Ahmad Basharat, Atif Butt, Sakina Abbas, Hovra Zahoor, Fizza Mohsin, Iqra Anwar, Muhammad Kashif Amin, Muhammad Salman Faisal, Michael V. Jaglal
Journal: Blood (2023)
The Impact of Iron Deficiency Anemia on Cerebrovascular Physiology, Brain Structure, and Cognitive Function in Otherwise Healthy Women
Authors: Silvie Suriany, Clio Gonzalez-Zacarias, Chau Vu, Sharon O'Neil, Gagan Mathur, Dawn Ward, Alyssa Ziman, Ellen B. Klapper, Lefan Zhuang, Christopher C Denton, John C. Wood
Journal: Blood (2023)
Genome-Wide CRISPR Screen Identifies MAD2L1BP, ANAPC15 and SLC39A7 As Intrinsic Regulators for Brentuximab Vedotin Sensitivity in Peripheral T-Cell Lymphoma Cells
Authors: Keito Suto, Masahiro Chiba, Takashi Ishio, Hideki Goto, Tomoyuki Endo, Michiyuki Maeda, Takanori Teshima, Masao Nakagawa
Journal: Blood (2023)
Non-Canonical Transcription Activator Activity of RNA-Binding Protein MBNL1 Uniquely Controls <i>FLT3</i> expression in MLL-Rearranged Leukemias
Authors: Siqi Yi, Shaela Wright, Meixia Che, Judith Hyle, Shelby Mryncza, Beisi Xu, Yong Cheng, Yajun Jiang, Chunliang Li
Journal: Blood (2023)
Outcomes in Routine Clinical Practice with Methotrexate-Temozolomide-Rituximab Induction and Modified Etoposide-Cytarabine Consolidation in Newly Diagnosed Primary CNS Lymphoma
Authors: Bhausaheb Bagal, Lingaraj Nayak, Nishant Jindal, Hasmukh Jain, Anant Gokarn, Alok Shetty, Jayant Goda, Sachin Punatar, Sumeet Mirgh, Sridhar Epari, Sangeeta Kakoti, Abhishek Chatterjee, Archa Dasgupta, Prashant Tembhare, Sweta Rajpal, Gaurav Chatterjee, Nikhil Patkar, Papagudi Ganesan Subramanian, Tanuja Shet, Tejpal Gupta, Siddhartha Laskar, Sumeet Gujral, Manju Sengar, Navin Khattry
Journal: Blood (2023)
Inflammatory Signatures Define a New High-Risk T-Lineage ALL Subtype
Authors: Mark Gower, Ximing Li, Alicia Aguilar-Navarro, Brian Lin, Minerva Fernandez, Gibran Edun, Mursal Nader, Andrea Arruda, Anne Maria Tierens, Elvin Wagenblast, Lin Yang, Ho Seok Lee, Sanam Loghavi, John E. Dick, Mark D. Minden, Johann K. Hitzler, Courtney L Jones, Gregory Schwartz, Igor Dolgalev, Soheil Jahangiri, Anastasia N. Tikhonova
Journal: Blood (2023)
The HLA-B Leader MM Genotype Has a Negative Impact on Outcomes in HLA-B One Antigen Mismatched and HLA-B Matched Cord Blood Transplantation without Anti-Thymocyte Globulin: Analysis of the Japanese Society for Transplantation and Cellular Therapy
Authors: Minoru Kanaya, Daigo Hashimoto, Yasuo Morishima, Nobuyoshi Arima, Masahiro Hirayama, Makoto Murata, Naoyuki Uchida, Masatsugu Tanaka, Yasufumi Uehara, Shigesaburo Miyakoshi, Kazuya Ishiwata, Makoto Onizuka, Satoshi Takahashi, Hikaru Kobayashi, Masashi Sawa, Koji Kato, Fumihiko Ishimaru, Tatsuo Ichinohe, Yoshiko Atsuta, Satoko Morishima
Journal: Blood (2023)
High Prevalence of <i>IDH</i> Mutation in Myeloid Neoplasm with Concomitant Autoimmune Rheumatic Disorders
Authors: Lih En Hong, Chung Hoow Kok, Monika Kutyna, Joule J Li, Rakchha Chhetri, David M. Ross, Susan Branford, Hamish S Scott, Anna Brown, Christopher Norman Hahn, David T Yeung, Mrinal M. Patnaik, Mithun V Shah, Susanna Proudman, Mihir Wechalekar, Devendra Hiwase
Journal: Blood (2023)
Multi-Hit <i>TP53</i> Mutations in Myeloid Neoplasms: Prognostic Impact of Morphologic Subtype Designation and Variant Allele Frequency
Authors: Maymona Abdelmagid, Kaaren K. Reichard, Omer Karrar, Rong He, Patricia Greipp, Rhett Ketterling, Mithun V Shah, Devendra Hiwase, Attilio Orazi, Daniel A. Arber, Naseema Gangat, Ayalew Tefferi
Journal: Blood (2023)
Glofitamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma: Extended Follow-Up from a Pivotal Phase II Study and Subgroup Analyses in Patients with Prior Chimeric Antigen Receptor T-Cell Therapy and by Baseline Total Metabolic Tumor Volume
Authors: Martin Hutchings, Carmelo Carlo-Stella, Franck Morschhauser, Lorenzo Falchi, Emmanuel Bachy, Guillaume Cartron, Cyrus Khan, Monica Tani, Joaquin Martinez-Lopez, Nancy L. Bartlett, Antonio Salar, Joshua Brody, Sirpa Leppä, Pauline Baumlin, Estefania Mulvihill, James Relf, Yuying Xie, Derrick Kaufman, Linda Lundberg, Michael Dickinson
Journal: Blood (2023)
Efficacy and Safety of Recombinant Thrombopoietin Combined with Immunosuppressive Therapy for Primary Treatment of Severe Aplastic Anemia: A Single-Center, Open-Label, Randomized, Clinical Trial
Authors: Wenrui Yang, Xin Zhao, Guangxin Peng, Huihui Fan, Kang Zhou, Lei Ye, Jianping Li, Yuan Li, Liping Jing, Li Zhang, Fengkui Zhang
Journal: Blood (2023)
Comparison of Methotrexate Maintenance Versus Autologous Stem Cell Transplant Consolidation after High-Dose Methotrexate-Based Induction Therapy in Primary Central Nervous System Lymphoma
Authors: Steven R Hwang, Patrick B Johnston, Richard C. Godby, Brianna Gysbers, Raphael Mwangi, Ivana Micallef, Stephen M Ansell, Luis Porrata, Urshila Durani, Gita Thanarajasingam, Matthew J. Maurer, Thomas M. Habermann, Arushi Khurana
Journal: Blood (2023)
A Phase 1 Study of CD38-Bispecific Antibody (XmAb18968) for Patients with CD38 Expressing Relapsed/Refractory Acute Myeloid Leukemia
Authors: Guru Subramanian Guru Murthy, Jessica T. Leonard, Talha Badar, Cecilia Y. Arana Yi, Adam S Duvall, Bijal D. Shah, Arielle Baim, Tyce Kearl, Alexandra M. Harrington, Aniko Szabo, Ehab L. Atallah
Journal: Blood (2023)
Correlation between Real-World Progression-Free Survival (rwPFS) and Overall Survival (OS) in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Who Relapsed or Are Refractory, Intolerant, Resistant to Treatment with a Bruton's Tyrosine Kinase Inhibitor (BTKi)
Authors: Kevin H. Lin, Lynn Huynh, Xiaoqin Yang, Enrico Zanardo, Lisa Matay, Megan Pinaire, Daria Liborski, Mikaela M. McDonough, Jillian Foreman, Mohammed Z.H. Farooqui, Enrico De Nigris, Shravanthi R. Gandra, Eric M. Sarpong, Mei Sheng Duh, Jennifer R. Brown, Matthew S Davids
Journal: Blood (2023)
Genome-Wide Mapping of R-Loops in Single Cells Reveals Cell-Type Specific Roles for R-Loops in Hematopoietic Cell Identity
Authors: Bin Lu, Pu Zhang, Sisi Chen, Salima Benbarche, Cynthia Castro, Nina Fox, Mohammad Abubakar, Jeetayu Biswas, Ruslan Soldatov, Richard Koche, Omar Abdel-Wahab
Journal: Blood (2023)
<i>Senza5 TM CART5</i>: An Autologous CD5-Deleted Anti-CD5 CART Product with Enhanced Anti-T-Cell Lymphoma Activity
Authors: Adam E. Snook, Ruchi P. Patel, Guido Ghilardi, Aditya Nimmagadda, Steven Yang, Dean Qian, Patrizia Porazzi, Rosemary Mazanet, Stephen J Schuster, Stefan K. Barta, Trang Vu, Marco Ruella, Nicholas A. Siciliano
Journal: Blood (2023)
A Pro-Inflammatory State and Peak Cytokines Are Associated with Toxicity and Early Responses in Real-World Multiple Myeloma Patients Treated with Idecabtagene Vicleucel
Authors: Doris K. Hansen, Lauren C. Peres, Julieta Abraham Miranda, Kayla Reid, Gabriel De Avila, David Huggar, Pallavi Patwardhan, Laura B. Oswald, Ariel F. Grajales-Cruz, Brandon Blue, Hien Liu, Taiga Nishihori, Kenneth Shain, Rachid Baz, Melissa Alsina, Omar Castaneda, Simran K. Tiwana, Afraim Botros, Frederick L. Locke, Ciara Louise L. Freeman
Journal: Blood (2023)
Consensus-Based Best Practice Recommendations for Myelofibrosis Management in Routine Clinical Practice with a Focus on Patients with Cytopenias: Systematic Literature Review and Clinical Practice Recommendations from a Global Consensus Group
Authors: Claire N Harrison, Prithviraj Bose, Martin H. Ellis, Vikas Gupta, Jean-Jacques Kiladjian, John Mascarenhas, Vikram Mathews, Francesco Passamonti, Steffen Koschmieder
Journal: Blood (2023)
Taste Abnormalities Emerging during Anti-Myeloma Therapies Including GPRC5D x CD3 Bispecific Antibody Talquetamab
Authors: Anna Fleischer, Magdalena Roll, Franziska Panther, Goetz Gelbrich, Franziska Reinhardt, Christine Riedhammer, Julia Mersi, Johannes M Waldschmidt, Hermann Einsele, K. Martin Kortüm, Imad Maatouk, Leo Rasche
Journal: Blood (2023)
Sustained Recovery of Uninvolved Heavy/Light Chain Pair Immunoparesis during Maintenance Discriminates Patients with Sustained Negative Minimal Residual Disease
Authors: Sunil Lakhwani, Laura Rosiñol, Noemi Puig, Miguel Angel Pico Picos, Laura Medina-González, Joaquin Martinez Lopez, Bruno Paiva, Maria Teresa Cedena Romero, Albert Oriol, Rafael Ríos, María Jesús Blanchard, Isidro Jarque, Joan Bargay, Jose Maria Moraleda, Estrella Carrillo-Cruz, Anna Maria Sureda Balari, Isabel Krsnik, Esther Gonzalez Garcia, Luis Felipe Casado Montero, Josep Maria Marti Tutusaus, Cristina Encinas Rodriguez, Felipe De Arriba, Luis Palomera, Antonia Sampol Mayol, Yolanda González-Montes, Cristina Motlló, Javier De la Cruz, Rafael Alonso Fernández, Maria-Victoria Mateos, Joan Blade Creixenti, Juan Jose Lahuerta Palacios, Jesus San Miguel, Miguel Teodoro Hernández Garcia
Journal: Blood (2023)
Bivalent BCMA Binding and Low Affinity CD3 T-Cell Engagement By Abbv-383 Drives Sustained Activation with Reduced T-Cell Exhaustion in Preclinical Models of Multiple Myeloma
Authors: David Sharon, Valerie Robinson, Claudie Hecquet, Kelly Calabrese, Cormac Cosgrove, Christine Mantis, Orlando Bueno, Aarif Ahsan, Adam Chervin, PK Epling-Burnette, Jeremy A Ross
Journal: Blood (2023)
Impact of Pre-Transplant Minimal Residual Disease in Patients with Multiple Myeloma with ≥ Very Good Partial Response Receiving Autologous Hematopoietic Stem Cell Transplantation
Authors: Oren Pasvolsky, Sarah Pasyar, Roland L. Bassett, Hina N. Khan, Mark R. Tanner, Qaiser Bashir, Samer A. Srour, Neeraj Y. Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Hans C. Lee, Krina K. Patel, Partow Kebriaei, Sheeba K. Thomas, Donna M. Weber, Robert Z. Orlowski, Elizabeth J. Shpall, Richard E. Champlin, Muzaffar H. Qazilbash
Journal: Blood (2023)
A Comparison of Acute Myeloid Leukemia (AML) Regimens: Hypomethylating Agents Combined with Ivosidenib or Venetoclax in Newly Diagnosed Patients with IDH1 Mutations: A Real-World Evidence Study
Authors: B. Douglas Smith, Curtis A Lachowiez, Alexander Joseph Ambinder, Gary Binder, Anne Angiolillo, Assaf Vestin, Robert Paglia, Ravi Potluri, Eros Papademetriou, Thomas W LeBlanc
Journal: Blood (2023)
Patient-Reported Outcomes: Danicopan As Add-on Therapy to Ravulizumab or Eculizumab Versus Placebo in Patients with Paroxysmal Nocturnal Hemoglobinuria and Clinically Significant Extravascular Hemolysis
Authors: Caroline I Piatek, Jong-Wook Lee, Morag Griffin, Jun-Ichi Nishimura, Christopher J. Patriquin, Hubert Schrezenmeier, Wilma Barcellini, Jamile Shammo, Anna Gaya, Yogesh Patel, Peng Liu, Karl-Johan Myrén, Flore Sicre De Fontbrune, Jens Panse, Austin Kulasekararaj
Journal: Blood (2023)